High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …

Breast cancer (BC) is a common cause of morbidity and mortality, particularly in women.
Moreover, the discovery of diagnostic biomarkers for early BC remains a challenging task …

Breast cancer (BC) is a major cause of human morbidity and mortality, especially among
women. Despite the important role of metabolism in the molecular pathogenesis of cancer …

In recent years, metabolites have attracted substantial attention as promising novel
biomarkers of various diseases. However, breast cancer plasma metabolite studies are still …

Breast cancer remains the most leading cause of death among women worldwide. Common
methods for diagnosis and surveillance include mammography, histopathology and blood …

Metabolomic approaches have been used to identify new diagnostic biomarkers for various
types of cancers, including breast cancer. In this study, we aimed to identify potential …

Objective Breast cancer (BC) is still a lethal threat to women worldwide. An accurate
screening and diagnosis strategy performed in an easy-to-operate manner is highly …

Background More accurate diagnostic methods are pressingly needed to diagnose breast
cancer, the most common malignant cancer in women worldwide. Blood-based …

Breast cancer accounts for the largest number of newly diagnosed cases in female cancer
patients. Although mammography is a powerful screening tool, about 20% of breast cancer …

Purpose Metabolomics is the comprehensive global study of metabolites in biological
samples. In this retrospective pilot study we explored whether serum metabolomic profile …